Gradient Investments LLC Sells 37,538 Shares of Procter & Gamble Company (The) $PG

Gradient Investments LLC trimmed its stake in Procter & Gamble Company (The) (NYSE:PG) by 14.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 215,788 shares of the company’s stock after selling 37,538 shares during the period. Gradient Investments LLC’s holdings in Procter & Gamble were worth $34,379,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Nova Wealth Management Inc. bought a new stake in Procter & Gamble in the first quarter valued at $26,000. Capital A Wealth Management LLC bought a new stake in Procter & Gamble in the fourth quarter valued at $31,000. Quarry LP bought a new stake in Procter & Gamble in the first quarter valued at $33,000. 10Elms LLP bought a new stake in Procter & Gamble in the fourth quarter valued at $34,000. Finally, Sunbeam Capital Management LLC bought a new stake in Procter & Gamble in the fourth quarter valued at $34,000. 65.77% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 13,039 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This represents a 31.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer directly owned 319,375 shares in the company, valued at $50,228,106.25. The trade was a 11.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 120,181 shares of company stock valued at $18,918,012 over the last ninety days. Company insiders own 0.20% of the company’s stock.

Procter & Gamble Trading Down 0.4%

Shares of PG opened at $158.02 on Monday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The firm has a market capitalization of $369.85 billion, a PE ratio of 24.27, a price-to-earnings-growth ratio of 4.17 and a beta of 0.36. The stock’s fifty day simple moving average is $156.21 and its 200-day simple moving average is $161.77.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the firm posted $1.40 earnings per share. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s dividend payout ratio is 64.82%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on PG shares. Barclays set a $164.00 price target on Procter & Gamble and gave the company an “equal weight” rating in a research report on Thursday, July 31st. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. BNP Paribas reissued an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reissued an “in-line” rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Wells Fargo & Company reduced their price objective on Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $175.12.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.